Literature DB >> 7710361

Identification and characterization of a cDNA clone derived from the Marek's disease tumour cell line RPL1 encoding a homologue of alpha-transinducing factor (VP16) of HSV-1.

D Koptidesová1, J Kopácek, V Zelník, N L Ross, S Pastoreková, J Pastorek.   

Abstract

We have identified and sequenced a 2.3 kb cDNA clone RPL(N.S) 6 derived from the Marek's disease virus (MDV)-transformed cell line RPL1, which contained open reading frames (ORFs) homologous to UL49 (VP22) and UL48 (VP16) of herpes simplex virus. Northern blot hybridization identified a 2.5 kb transcript corresponding to this cDNA clone in the total RNA from MSB1 lymphoblastoid cells, but not in RNA from the original RPL1 cells, most probably due to the very low level of its transcription. In vitro translation demonstrated that both MDV UL49 and UL48 can be expressed from a single mRNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710361     DOI: 10.1007/bf01309869

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Detailed analysis of the mRNAs mapping in the short unique region of herpes simplex virus type 1.

Authors:  F J Rixon; D J McGeoch
Journal:  Nucleic Acids Res       Date:  1985-02-11       Impact factor: 16.971

2.  DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters.

Authors:  M A Dalrymple; D J McGeoch; A J Davison; C M Preston
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

3.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

4.  Structure of Marek's disease virus DNA: detailed restriction enzyme map.

Authors:  K Fukuchi; M Sudo; Y S Lee; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification.

Authors:  A E Buckmaster; S D Scott; M J Sanderson; M E Boursnell; N L Ross; M M Binns
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

6.  A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).

Authors:  K Nazerian; E A Stephens; J M Sharma; L F Lee; M Gailitis; R L Witter
Journal:  Avian Dis       Date:  1977 Jan-Mar       Impact factor: 1.577

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters.

Authors:  H Moriuchi; M Moriuchi; S E Straus; J I Cohen
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 9.  The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; M A Dalrymple; A J Davison; A Dolan; M C Frame; D McNab; L J Perry; J E Scott; P Taylor
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

10.  Differential response of human interferon-beta promoter elements to trans-activation by HSV VP16 and IRF-1.

Authors:  J F Leblanc; J Hiscott
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  7 in total

Review 1.  Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

Authors:  Shaw-Wei D Tsen; Augustine H Paik; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

2.  The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16.

Authors:  V Misra; S Walker; S Hayes; P O'Hare
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Sequence and function of canine herpesvirus alpha-transinducing factor and its interaction with an immediate early promoter.

Authors:  Scott G Tyack; Michael J Studdert; Michael A Johnson
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

4.  Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen.

Authors:  Chien-Fu Hung; Liangmei He; Jeremy Juang; Tzyy-Jye Lin; Morris Ling; T-C Wu
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Herpesvirus of turkeys homologue of HSV VP16 is structurally related to varicella zoster virus trans-inducing protein encoded by ORF 10.

Authors:  J Kopácek; V Zelník; R Brasseur; D Koptidesová; O Rejholcová; S Pastoreková; J Pastorek
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 6.  DNA vaccines for cervical cancer: from bench to bedside.

Authors:  Chien-Fu Hung; Archana Monie; Ronald D Alvarez; T-C Wu
Journal:  Exp Mol Med       Date:  2007-12-31       Impact factor: 8.718

Review 7.  Therapeutic HPV DNA vaccines.

Authors:  Archana Monie; Shaw-Wei D Tsen; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.